BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Australian Diabetes Society - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.diabetessociety.com.au
X-WR-CALDESC:Events for Australian Diabetes Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20241205T190000
DTEND;TZID=Australia/Melbourne:20241205T200000
DTSTAMP:20260601T131912
CREATED:20241113T045653Z
LAST-MODIFIED:20241119T020054Z
UID:10000076-1733425200-1733428800@www.diabetessociety.com.au
SUMMARY:The Role of GLP-1 Based Therapies in Liver Fibrosis and MASH
DESCRIPTION:Join us on Thursday\, 5 December 2024 from 7:00 pm to 8:00 pm (AEDT) as we discuss the latest trials on the management of MASH in people with and without diabetes. We’ll focus on the Australian clinical context\, considering GESA’s recent position statement on MAFLD screening and diagnosis as well as ADS’ provision statement on managing the condition. \nThis webinar will cover: \n\n\nEpidemiology and diagnosis of MAFLD and MASH\nKey clinical studies and outcomes\nAustralian position statements/guidelines\nImplications for the clinical management of MASH\n\n\nSpeakers\n \nClick here to view the event flyer.\nClick here to register for the webinar. \nRegistration is free to attend. \nFor any further information please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\nThe ADS gratefully acknowledges the support from Novo Nordisk for this educational diabetes webinar.
URL:https://www.diabetessociety.com.au/event/glp1-therapies-mafld-mash/
LOCATION:VIC
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2024/11/ADS-GESA-Webinar_5-Dec-2024-3.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
END:VCALENDAR